Intuitive Surgical, Inc. ISRG
Verdict: Strong sell. Fair value $307 against a price of $566 on 6 Jan 2026, 46% below the price.
In plain words
The case for: Wide competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: The OCF / Net Income ratio has trended down from a high of 1.23 in 2021 to 1.04 in 2024 (2021:....
Main risks
- Volatile Free Cash Flow: FCF dropped from $1.75B in 2021 to a low of $0.75B in 2023 before recovering. This volatility suggests potential inconsistencies in working capital management or high non-cash expenses.
- Low Incremental Return on Capital (ROIIC): The calculated 3-year ROIIC is very low at ~4.4%. This is a significant concern, suggesting that the vast amounts of retained earnings are not being reinvested at high rates of return, a potential sign of maturing growth or inefficient capital allocation.
- High Market Volatility (Beta): A beta of 1.67 indicates the stock is substantially more volatile than the overall market, posing a higher risk profile for investors despite its large-cap status.
- Valuation prices in optimistic scenario (limited margin for error)
- Market volatility
- Execution risk